E
ZYUS Life Sciences Corporation ZYUS.V
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Net Income 18.31% -42.03% 86.24% -475.71% 53.73%
Total Depreciation and Amortization -0.51% -0.65% -10.72% 5.72% 26.44%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 38.26% -5.71% -98.92% 13,096.94% -103.11%
Change in Net Operating Assets -58.45% 1,568.01% -119.28% 123.73% -292.42%
Cash from Operations -238.62% 83.46% 5.46% 67.74% -73.76%
Capital Expenditure -- 100.00% 82.14% -440.61% -480.00%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- -100.00%
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- 100.00% 82.14% -440.61% -100.71%
Total Debt Issued -25.00% -- -- -- -100.00%
Total Debt Repaid -2,919.77% 74.78% -2.10% 39.38% 82.56%
Issuance of Common Stock -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 224.58% 190.75% -3.01% 40.24% -103.53%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -281.02% 95.78% 9.03% 64.15% -159.05%
Weiss Ratings